Fortitude Family Office’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$751 Sell
9
-5
-36% -$411 ﹤0.01% 2314
2026
Q2
$930 Buy
14
+5
+56% +$423 ﹤0.01% 1775
2026
Q1
$895 Buy
9
+5
+125% +$652 ﹤0.01% 1536
2025
Q4
$487 Buy
+4
New +$502 ﹤0.01% 1724

Other funds holding TMDX

Fortitude Family Office's TMDX Position: Q3 2026 in Review

Fortitude Family Office reduced its Transmedics (TMDX) stake by 36% in Q3 2026, selling an estimated $411 and leaving 9 shares worth $751. The position accounts for ﹤0.01% of the portfolio, ranked #2314.

Fortitude Family Office first reported a position in TMDX in Q4 2025 and has held it in 4 quarters since. The position peaked at $930 in Q2 2026. 33 funds tracked by Wall St. Rank hold TMDX as of Q3 2026.

  • Fortitude Family Office held 9 shares of Transmedics worth $751 as of Q3 2026.
  • Fortitude Family Office sold 5 Transmedics shares in Q3 2026, an estimated $411.
  • Transmedics made up ﹤0.01% of Fortitude Family Office's portfolio in Q3 2026, its #2314 holding.
  • Fortitude Family Office first reported a position in Transmedics in Q4 2025 and has held it in 4 quarters since.
  • Fortitude Family Office's Transmedics position peaked at $930 in Q2 2026.
  • 33 funds tracked by Wall St. Rank held Transmedics as of Q3 2026.

Based on Fortitude Family Office's 13F filing for Q3 2026, filed 14 Oct 2026.